PubMed Health⌕ Search

PubMed · 7896955

Textile dye dermatitis.

Abstract

The literature concerning textile dye dermatitis published during the last decade was reviewed. Sixty-one cases of dye-allergic contact dermatitis in which the presentation or course of the dermatitis was unusual or the dye allergen was one not previously reported have been described. The four new dye allergens discovered were Disperse Blue 106, Disperse Blue 85, Disperse Brown 1, and Basic Red 46. The incidence of dye dermatitis varied from 1% to 15.9% depending on the country, patient sample, and number of dyes in the patch test series. The 10 new dye allergens discovered in these studies were Disperse Blue 153, Disperse Orange 13, Basic Black 1, Basic Brown 1, the acid dyes Supramine Yellow and Supramine Red, the direct dye Diazol Orange, the basic dye Brilliant Green, Turquoise Reactive, and Neutrichrome Red. Disperse Blue 106 and Disperse Blue 124 were shown to be the strongest clothing dye sensitizers to date. Standard screening patch test series were found to be inadequate for the detection of textile dye sensitivity; therefore textile dye patch test series should be used. It is difficult to determine whether the incidence of dye dermatitis is increasing or decreasing because controlled epidemiologic studies are lacking, but data suggest that textile dye sensitivity is more common than previously believed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K L Hatch, H I Maibach. 1995. Textile dye dermatitis.. https://doi.org/10.1016/0190-9622(95)90350-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.

Allergen-specific immunotherapy represents one of the few curative approaches toward type I allergy. Up to 25% of allergic patients are sensitized against the major birch pollen allergen, Bet v 1. By genetic engineering we produced two recombinant (r) Bet v 1 fragments comprising aa 1-74 and aa 75-160 of Bet v 1, which, due to a loss of their native-like fold, failed to bind IgE Abs and had reduced allergenic activity. Here we show that both fragments covering the full Bet v 1 sequence induced human lymphoproliferative responses similar to rBet v 1 wild type. The C-terminal rBet v 1 fragment induced higher lymphoproliferative responses than the N-terminal fragment and represented a Th1-stimulating segment with high IFN-gamma production, whereas the N-terminal fragment induced higher IL-4, IL-5, and IL-13 secretion. Immunization of mice and rabbits with rBet v 1 fragments induced IgG Abs, which cross-reacted with complete Bet v 1 and Bet v 1-related plant allergens and strongly inhibited the IgE binding of allergic patients to these allergens. Thus, our results demonstrate that hypoallergenic T cell epitope-containing rBet v 1 fragments, despite lacking IgE epitopes, can induce Abs in vivo that prevent the IgE binding of allergic patients to the wild-type allergen. The overall demonstration of the immunogenic features of the hypoallergenic rBet v 1 fragments will now enable clinical studies for safer and more efficient specific immunotherapy.

Allergens↗

Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma.

The relationship between eosinophils and the development of Ag-induced pulmonary pathologies, including airway hyper-responsiveness, was investigated using mice deficient for the secondary granule component, major basic protein-1 (mMBP-1). The loss of mMBP-1 had no effect on OVA-induced airway histopathologies or inflammatory cell recruitment. Lung function measurements of knockout mice demonstrated a generalized hyporeactivity to methacholine-induced airflow changes (relative to wild type); however, this baseline phenotype was observable only with methacholine; no relative airflow changes were observed in response to another nonspecific stimulus (serotonin). Moreover, OVA sensitization/aerosol challenge of wild-type and mMBP-1(-/-) mice resulted in identical dose-response changes to either methacholine or serotonin. Thus, the airway hyper-responsiveness in murine models of asthma occurs in the absence of mMBP-1.

Allergens↗